Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Rate of patients with complete response (CR) of L19IL2 treated metastases at week 12
Critère d'inclusion
- Cancer- Patients with histopathologically-proven malignant melanoma with presence of measurable and injectable dermal or subcutaneous metastases either in clinical stage III or stage IV